diethyl-(6-hydrazino-pyridazin-3-yl)-amine | 160951-65-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: diethyl-(6-hydrazino-pyridazin-3-yl)-amine
• 英文别名: N,N-diethyl-6-hydrazinylpyridazin-3-amine
• CAS: 160951-65-5
• 化学式: C₈H₁₅N₅
• mdl: MFCD08436548
• 分子量: 181.241
• InChiKey: YTPWGMWEYJWSKG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  67.1
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  diethyl-(6-hydrazino-pyridazin-3-yl)-amine 在 sodium acetate 作用下， 以 甲醇 、 乙醇 为溶剂， 反应 4.0h， 生成 1-{2-[(6-Diethylamino-pyridazin-3-yl)-hydrazonomethyl]-phenoxy}-3-isopropylamino-propan-2-ol
  参考文献：
  名称：

  Studies on Agents with Vasodilator and .BETA.-Blocking Activities. I.

  摘要：

  合成了一系列与β-封端侧链结合的肼基哒嗪衍生物。当将它们静脉注射给麻醉大鼠时，其中一些表现出降血压和β-阻滞活性。讨论了它们的降血压和β-阻滞活性的结构-活性关系。化合物 11c 具有最佳特征，被选择用于进一步研究。

  DOI：

  10.1248/cpb.42.1609

文献信息

• Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines
  作者：Elvio Bellasio、Ambrogio Campi、Nunzio Di Mola、Emiliana Baldoli

  DOI：10.1021/jm00374a024

  日期：1984.8

  The hypothesis that the side effects of hydralazine, such as mutagenicity and lupus erythematosus like syndrome, might be due to the NHNH2 group prompted us to incorporate part of this moiety into a pyrrole ring. Therefore, we prepared a series of N-1H-pyrrol-1-yl-3-pyridazinamines and a limited number of N-1H-pyrrol-1-yl-1-phthalazinamines by reaction of 3-hydrazinopyridazines and 1-hydrazinophthalazines with gamma-diketones. Most of these compounds, especially in the pyridazine series, showed moderate to strong antihypertensive activity in spontaneously hypertensive rats. The decrease in blood pressure generally had a slow onset after either oral or intravenous administration. N-(2,5-Dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (30) (MDL 899) showed no mutagenic activity in several tests and is now in clinical trials in patients.
• Studies on Agents with Vasodilator and .BETA.-Blocking Activities. I.
  作者：Toshimi SEKI、Takayuki TAKEZAKI、Rikio OHUCHI、Hiroshi OHUYABU、Tsutomu ISHIMORI、Kikuo YASUDA

  DOI：10.1248/cpb.42.1609

  日期：——

  A series of hydrazinopyridazine derivatives combined with a β-blocking side chain were synthesized. When they were given intravenously to anesthetized rats, some of them exhibited both hypotensive and β-blocking activities. Their structure-activity relationships for hypotensive and β-blocking activities are discussed. Compound 11c had the best profile and was selected for further study.

  合成了一系列与β-封端侧链结合的肼基哒嗪衍生物。当将它们静脉注射给麻醉大鼠时，其中一些表现出降血压和β-阻滞活性。讨论了它们的降血压和β-阻滞活性的结构-活性关系。化合物 11c 具有最佳特征，被选择用于进一步研究。